Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05272995
Other study ID # 114/21-02-2022
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 24, 2022
Est. completion date October 1, 2022

Study information

Verified date March 2022
Source University Hospital of Patras
Contact Stavros Kontogiannis
Phone 00306974678699
Email stavroskontogiannis@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The accurate assessment of erectile function before radical prostatectomy, using validated questionnaires like IIEF-5, is crucial to evaluate postoperative changes in erectile function, as the preoperative erectile function is a prognostic factor for the postoperative recovery of erectile function. In clinical practice, patients usually present at the urologist's office 3 months after the operation without a preoperative IIEF-5 score and at that time the doctors ask them about their preoperative erectile function. With this study, the investigators would like to evaluate the agreement between a real-time preoperative IIEF-5 and a recalled one 3 months after radical prostatectomy.


Description:

Radical prostatectomy (RP) is a widely performed procedure for patients with clinically localized prostate cancer and its most common side effects include urinary incontinence and erectile dysfunction. These two side-effects become progressively more important to health-related quality of life (HRQOL) and thus the balance between cancer control and preservation of HRQOL is challenging. The postoperative changes in erectile function are directly related with the preoperative erectile function status of the patient. The most accurate evaluation of the pretreatment erectile function is the International Index of Erectile Function-5 questionnaire. The fact that in some cases the preoperative questionnaire results are negatively affected by several factors, indicates the necessity of the assessment of the degree of agreement between real time IIEF-5 scores and retrospective IIEF-5 scores after radical prostatectomy. Frequently the andrologists do not have a preoperative IIEF-5 score in their hands and this might happen for various reasons. The main reason is that urologists ask about the preoperative erectile function often with just a simple question. They rarely use a questionnaire mainly due to time constraints. According to the experience at the Sexual Rehabilitation Clinic of the University's General Hospital of Patras, 3 months is the usual time point when most patients come to the clinic after radical prostatectomy. In the first two months after surgery, patients are interested primarily in the oncological and continence issues and later they seek help for their erectile dysfunction.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date October 1, 2022
Est. primary completion date July 1, 2022
Accepts healthy volunteers No
Gender Male
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: - Men above 18 years old wih clinically localized prostate cancer, who have undergone open or laparoscopic radical prostatectomy, with or without use of phosphoodiesterase-5 inhibitors Exclusion Criteria: - Penile anatomic defects - Uncontrolled major medical illnesses such as uncontrolled diabetes, severe renal, hepatic or cardiovascular disease - major psychiatrics disorders - drug or alcohol abuse

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
IIEF-5
The participants will be asked to complete a validated IIEF-5 questionnaire, an abridged version of the IIEF. The IIEF is a validated, brief and reliable self-administered questionnaire for assessing erectile function. Moreover, this tool is easily administered in clinical setting and demonstrates adequate sensitivity and specificity for detecting treatment-related changes in erectile function in patients with erectile dysfunction (ED).According to Rosen et al the abridged five-item version of the 15-item IIEF possesses favorable properties for detecting the presence and severity of ED for the preceding 6 months. The IIEF-5 consists of five questions, each of which is scored on a five-point ordinal scale and ED may be classified into five categories based on the calculated scores.

Locations

Country Name City State
Greece University of Patras Patras Achaia

Sponsors (1)

Lead Sponsor Collaborator
University Hospital of Patras

Country where clinical trial is conducted

Greece, 

Outcome

Type Measure Description Time frame Safety issue
Primary Score of recalled International Index of Erectile Function-5 Score of recalled IIEF-5 collected 3 months after radical prostatectomy. The IIEF is a validated, brief and reliable self-administered questionnaire for assessing erectile function. The abridged five-item version of the 15-item IIEF possesses favorable properties for detecting the presence and severity of erectile dysfunction for the preceding 6 months. The IIEF-5 consists of five questions, each of which is scored on a five-point ordinal scale and erectile dysfunction may be classified into five categories based on the calculated scores. Based on IIEF-5 scores, erectile dysfunction severity is classified into the following five categories: severe (5±7), moderate (8±11), mild to moderate (12±16), mild (17±21), and no erectile dysfunction (22± 25). 3 months
Primary Assessment of the degree of agreement between real time preoperative International Index of Erectile Function-5 score and recalled IIEF-5 3 months after radical prostatectomy Assessment of the degree of agreement between real time preoperative IIEF-5 score and recalled IIEF-5 3 months after radical prostatectomy 3 months
See also
  Status Clinical Trial Phase
Completed NCT05735223 - A Prospective Study to Evaluate the Impact of Maximal Urethral Length Preservation Technique During Robotic Laparoscopic Prostatectomy on the Stretched Flaccid Penile Length and Continence N/A
Recruiting NCT05868668 - Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain N/A
Completed NCT03241758 - Vascular Changes Of Patients Undergoing Laparoscopic Radical Prostatectomy N/A
Recruiting NCT05558007 - Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients Phase 2
Completed NCT05332340 - Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administered Phase 1
Completed NCT04491773 - Study of Retinal and Choriocapillary Vascular Changes in Patients Undergoing Tadalafil 20mg for More Than 6 Months
Recruiting NCT05650866 - Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction N/A
Recruiting NCT03905057 - Early Shockwave Therapy for Post-RP ED N/A
Not yet recruiting NCT06126874 - Additional Effects of Aerobic and Resistance Exercises to Pelvic Floor Muscle Training After Radical Prostatectomy N/A
Completed NCT05772598 - Validating the 'Sexual Minorities and Prostate Cancer Scale' to Gold Standard Questionnaires
Recruiting NCT05244486 - Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy N/A
Not yet recruiting NCT06458855 - Nerve Grafting Technique to Restore Erectile Function Post Radical Prostatectomy N/A
Completed NCT00335634 - Sexual Dysfunction and Adaptation in Couples Affected by Prostate Cancer Surgery N/A
Recruiting NCT03862599 - Low Intensity Shock-wave Therapy (Li-ESWT) in Penile Rehabilitation After Radical Prostatectomy N/A
Active, not recruiting NCT04434352 - Low Intensity Shockwave Therapy for Erectile Dysfunction N/A
Completed NCT04164355 - Study of Retinal and Choriocapillary Vascular Changes in Patients Undergoing Tadalafil 20mg
Not yet recruiting NCT05960149 - Use of Indocyanine Green in Robotic Prostate Surgeries Phase 4
Terminated NCT01996852 - Improving Erectile Function and Quality of Life After Prostate Cancer Treatment N/A
Recruiting NCT06076850 - Low-Intensity Extracorporeal Shockwave Therapy for Penile Rehabilitation in Post-Radical Prostatectomy Patients N/A
Terminated NCT01770340 - Nerve Grafting With an Allograft During Radical Prostatectomy - Extended Follow-up in a Prospective Randomized Trial Phase 4